STAT+: CAR-T research is flourishing but is hampered by outdated precautions, experts say
Twenty years ago, CAR-T cell therapy was not quite “believed in,” said Michel Sadelain, director…
Category: breakthrough23
STAT+: What the Covid-19 pandemic can teach us about drug patents
Inventing treatments and vaccines is only part of the battle in an epidemic and pandemic,…
Now 18, the first child to ever receive CAR-T cancer therapy is ready for a new identity
The Food and Drug Administration approves dozens of cancer drugs every year, but the vast…